Trademark: 98180421
Word
LYTENAVA
Status
Pending
Status Code
686
Status Date
Tuesday, September 3, 2024
Serial Number
98180421
Mark Type
4
Filing Date
Thursday, September 14, 2023
Published for Opposition
Tuesday, September 3, 2024
Trademark Owner History
Outlook Therapeutics, Inc. - Owner At Publication
Classifications
5 Injectable pharmaceutical preparations for the treatment of retinal disease; pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease
Trademark Events
Sep 18, 2023
New Application Entered
Oct 3, 2023
New Application Office Supplied Data Entered
May 8, 2024
Assigned To Examiner
May 14, 2024
Non-Final Action Written
May 14, 2024
Non-Final Action E-Mailed
May 14, 2024
Notification Of Non-Final Action E-Mailed
Jul 26, 2024
Approved For Pub - Principal Register
Aug 14, 2024
Notification Of Notice Of Publication E-Mailed
Sep 3, 2024
Published For Opposition
Sep 3, 2024
Official Gazette Publication Confirmation E-Mailed
ENGRAZE
HEALTH COMES FIRST
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - Twit Solutions PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov